Next Generation: Photoswitch Chemical Restores Sight

In blind mice, a light-stimulated small molecule temporarily confers photosensitivity to retinal ganglion cells despite rod and cone damage.

Written byLaasya Samhita
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Flat-mounted rat retina at 50x magnificationWIKIMEDIA, MEMORY LAPSEThe compound: Richard Kramer from the University of California, Berkeley, and his colleagues have restored sight to blind mice using a small molecule called DENAQ, which, as a photoswitch chemical, changes conformation in response to light. In healthy mice, vision is a result of the conversion of light energy to electrical energy by specialized photoreceptor cells in the eye. These cells—rods and cones—perceive light and transmit visual information to the retinal ganglion cells (RGCs), which in turn communicate with the brain. Millions of people suffer from progressive degeneration of the rods and cones, which can lead to blindness, such as with diseases like retinitis pigmentosa. However, even after the rods and cones die, RGCs typically remain functional, so researchers have been searching for ways to manipulate them into photosensitivity.

Kramer’s team previously showed that DENAQ could confer light sensitivity on certain voltage gated ion channels. In a paper published today (February 19) in Neuron, the researchers tested its action on three-month-old to six-month-old healthy mice, and on mice carrying a mutation causing nearly all their rods and cones to degenerate by the time they were a month old, by exposing the animals’ retinas to light and recording neuronal activity from the RGCs using an electrode array. They found that RGCs from the diseased-retina mice showed strong light sensitivity after DENAQ treatment.

Retinas with damaged rods and cones are subject to several morphological and biochemical changes, making them different from a healthy retina in more than one way. In this case, Kramer explained, their electrophysiology ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies